Background: Primary progressive aphasia (PPA) is a neurodegenerative disorder characterized by progressive deterioration of language. Being rare, reports of PPA in multilingual individuals are scarce, despite more than half of the world population being multilingual.
P rimary progressive aphasia (PPA) is a neurodegenerative syndrome characterized by the progressive deterioration of language with the relative sparing of other cognitive functions, because of a selective distribution of neurodegeneration within specific language networks. 1 On the basis of this selective language network dysfunction, 3 clinical variants have been identified: (1) nonfluent/agrammatic variant (PPA-G), (2) semantic variant (PPA-S), and (3) logopenic variant (PPA-L), 1,2 generally associated with frontotemporal lobar degeneration (FTLD) or Alzheimer disease (AD). 3 Epidemiological data for PPA is limited, but is characterized by low prevalence and incidence. 4, 5 It remains nonetheless surprising that only a few single cases of PPA have been reported in multilingual patients, considering that multilingualism is the norm for most individuals worldwide and will likely be increasing, because of globalization and migration phenomena.
The study of the influence of multilingualism, particularly bilingualism, on the development and normal function of language and other cognitive domains has a long history 6 and has provided important insights into several cognitive and clinical questions. One topic that has received considerable attention is the study of bilingual patients with aphasia due to focal brain damage, most frequently because of stroke. In the last 2 centuries theorical models of multilingual aphasia focused either on the influence of memory systems, or on the role of cognitive control. Both views reflect concepts on how the brain organizes languages, either separated or sharing common neural networks. 7 There are 3 main hypotheses regarding the deterioration pattern of language processing in bilingual aphasia: (1) Ribot's law, which postulates that the mother language (L1) would be more resistant to progressive cognitive deterioration processes; 8 (2) Pitre's rule, which defends that the dominant language would greatly benefit from therapeutic intervention; 8 and (3) the shared neuronal substrate hypothesis, which argues for parallel deterioration of both languages. 9 Considerably fewer studies have evaluated language deficits in bilingual patients with neurodegenerative diseases, 10 with the majority focusing on AD, specifically on deficits in semantic/lexical access. Earlier studies found that the nondominant language is frequently more impaired in bilingual AD patients, 11 although others have found a parallel impairment, 9 which has been attributed to supra-linguistic deficits in executive cognitive control mechanisms. 12 The role of different mediators in multilingual aphasia should not be understated. Several possible factors have been identified, including, among others, the type of bilingualism (simultaneous vs. sequential; receptive vs. productive; additive vs. subtractive), degree and balance of proficiency, age of acquisition, language characteristics and features (eg, transparency, writing systems type, distance, degree of exposure, cognate vs noncognate) and translation type, 6, 13, 14 but their effects on language impairment in neurodegenerative disorders are still poorly understood.
Some studies also assessed bilingualism as a potential protective factor in neurodegenerative disorders. 15 Despite some evidence on the association between bilingualism and later symptom onset in AD, 16 possibly mediated through an increase in cognitive reserve and neuroplasticity, 17 a recent study did not find an association between bilingualism and delayed symptom onset in PPA. 18 The aim of this retrospective study was to characterize the clinical manifestations of language decline in bilingual patients with PPA, with an emphasis on symptom onset, patterns of performance in different languages and identification of potential mediating factors.
METHODS
We conducted a systematic literature search of multilingual PPA and complemented it with 20 new cases retrospectively identified in our centers. For the systematic review, medical electronic search engine (PubMed) was used to identify studies on PPA and multilingualism, using the following search terms: (primary progressive aphasia OR semantic dementia OR logopenic aphasia) in combination with (bilingualism OR multilingualism) in September 2017, yielding 14 publications. Reference lists of the identified publications were also reviewed. Eligibility criteria included peer-reviewed reports with individual data on multilingual PPA patients diagnosed according to current criteria, 2 regardless of study type (cohort or case-report), PPA variant (nonfluent/agrammatic, semantic or logopenic), demographic or language characteristics. After screening, 4 records were excluded [2 because of data duplication and 2 reported on a different etiology (eg, stroke) or disorder (eg, nonprimary aphasia because of AD)]. In total, 13 previously published single cases were included in the analysis (cf. Supplementary Table 2 , Supplemental digital Content 1, http://links.lww.com/CLINSPINE/A76, for references). Follow-up or interventional studies were included, but only data from the baseline assessment were collected. In addition, 20 previously unpublished cases of multilingual patients with PPA were retrospectively identified in the databases of our centers (n = 14 in Toronto, n = 2 in Braga, n = 2 in Madrid, n = 1 in Washington and Aachen, respectively). Data from baseline assessments were collected from available clinical and research records. In all participating sites, diagnosis was established through interdisciplinary consensus, according to current criteria. 2 Patients were included in this study if diagnosed with PPA, regardless of variant, and classified as multilingual, which was broadly defined as the knowledge and use of 2 or more languages. 19 To minimize missing data, our design comprised the collection and analysis of L1 and L2, despite some patients being proficient in > 2 languages. Most of the variables were categorized to allow for comparability (see Table 1 Results are largely descriptive given the study exploratory nature, variability in assessment methods and small sample sizes. We present frequency, percentage, mean values with SD or median with interquartile range (IQR), depending on data characteristics. The study was authorized by the Ethics Committee of Hospital de Braga and conducted in agreement with the Helsinki Declaration.
RESULTS

Demographics
We present data on 33 multilingual PPA patients, 13 from the literature review and 20 previously unpublished cases identified in our centers (cf. Supplementary Table 2 , Supplemental digital Content 1, http://links.lww.com/ CLINSPINE/A76 for an overview on individual characteristics). As shown in Table 2 , 20 patients were male, and the mean age was 68.6 years (SD = 7.5). The majority were right-handed (left-handed n = 3, information missing for 3 cases) and had completed tertiary education level (57.6%, secondary level 21.2%, primary level 9.1%, information missing for 4 patients), with a heterogeneous sociocultural background, as evidenced by their occupational status (see Table 2 ), with a high frequency of management and teaching professionals.
Languages Profile
The array of first and second languages is heterogeneous, including 22 different languages as L1 and nine languages as L2 (see Supplementary Table 2 , Supplemental digital Content 1, http://links.lww.com/CLINSPINE/A76 for individual data). There were 10 multilingual patients, 8 of whom were fluent in a third language and 2 in a fourth or fifth additional language. Figure 1 depicts the frequency of L1 and L2 languages across patients. About 72% of L1 languages belonged to the Indo-European language family, 14% to Sino-Tibetan, 9% to Uralic and 5% to Afro-Asiatic; 67% of L2 languages belong to the Indo-European language family and 11% to Afro-Asiatic, Sino-Tibetan or Japonic language families, respectively.
As shown in Table 3 , L1 was the dominant language at time of assessment for 49% of patients. Most patients, even those with L2 perceived as dominant, used L1 on a daily basis. The majority had an early to middle age of L2 acquisition (33% early, 18% middle, and 24% late, with data missing for 3 patients). At the time of diagnosis, many patients used L2 daily, at work and/or at home, with only a minority using it occasionally. On the basis of qualitative information, most patients could be described as independent or proficient L2 users.
Clinical Characteristics
Fourteen patients were diagnosed with nonfluent/ agrammatic variant (PPA-G), 6 with semantic variant (PPA-S), and 13 with logopenic variant (PPA-L). As reported on Table 4 , the median symptom onset was 2 years (range, 1 to 6 y). The first symptom reported was word-finding difficulties in 67% of patients, anomia in 15%, effortful speech in 12% and comprehension problems in 6%. From the patients presenting with word-finding difficulties the majority had a diagnosis of PPA-L, followed by PPA-G and PPA-S. Most patients diagnosed with PPA-S presented initially with naming difficulties. Effortful speech was more frequently the first symptom of PPA-G. About half of published studies did not report data on previous medical history. A minority of patients had a history of traumatic brain injury and vascular risk factors. Information on learning disabilities was missing for almost all previously published patients. One patient reported a probable dyslexia. Nine patients had no information on family history, whereas 9 (5 with PPA-L and 4 with PPA-G) had a positive family history of dementia. Excluding speech and language abnormalities, all patients had an otherwise normal neurological examination (missing data n = 4). Apraxia of speech (AoS) was reported in 33% of patients, all classified as PPA-G.
Only 2 patients had no information on structural or functional imaging. Structural neuroimaging (n = 27) showed predominantly left frontotemporal atrophy for PPA-G (n = 7), predominately left anterior temporal atrophy for PPA-S (n = 3), and predominately left temporoparietal atrophy for PPA-L (n = 3). Some cases (n = 4) were described as showing global atrophy (PPA-G n = 3, PPA-L n = 1). Eleven patients had no reported neuroimaging structural abnormalities, the majority of which classified as PPA-L (n = 7). Regarding functional neuroimaging (n = 20), using fludeoxyglucose ( 
Language Impairment Profiles in L1 and L2
The first symptom was most frequently noticed in L2 (55% for the whole group). Regardless, there was a high degree of agreement (eg, Spanish-Spanish) between the FIGURE 1. The frequency of L1 (first language) and L2 languages. In total 22 including 22 different languages are represented. English was the most common first language (L1), followed by European Portuguese and Spanish. Most patients' second language (L2) was English (n = 19), and besides four French second language-speakers, other second languages included Spanish (n = 2), Italian (n = 2), Hebrew (n = 2), Catalan, German, Mandarin, and Japanese.
perceived dominant language and the language in which the first symptom was noticed (63%). Formal assessment in both languages was conducted in 45% of patients.
As shown in Figure 1 , the pattern of language severity per domain in each language is heterogeneous. At the time of diagnosis, naming deficits were conspicuous, with similar impairment in both L1 and L2, except for PPA-G where, irrespective of language dominance at the time of testing, L2 seems to be more severely impaired. Comprehension deficits were more severe in L1 in PPA-S than in L2, whereas this pattern was reversed in PPA-G, although global profiles between languages were similar. Severity of repetition deficits were comparable between languages in the different PPA variants. Semantic knowledge performance seemed comparable between languages at the whole-group level, even though there appeared to be a tendency for more severely impaired semantic knowledge in L2 in the PPA-S and PPA-G groups than in L1. In the PPA-L group, deficits appeared largely parallel when comparing L1 and L2 along the language domains.
DISCUSSION
The aim of our study was to characterize clinical manifestations and language characteristics of multilingualism of patients with PPA. As shown by our systematic review, reports of multilingual patients with PPA are scarce and limited to single-case reports. The data we present here represents the largest series assessing clinical and linguistic characteristics of multilingual PPA patients. Besides variability in the clinical and linguistic features of bilingual PPA cases, there is also considerable variability in data availability, which hinders comparisons with larger PPA studies in monolingual patients and limits generalization into different clinical and linguistic contexts.
Our case series is demographically in agreement with data from monolingual PPA reports. The higher frequency of male patients, as well as the mean age in our study, rendering its typical early-onset status, both resemble available epidemiological and clinical data. 4 The lack of a comparison group of monolingual patients does not allow us to test the hypothesis of multilingualism as a potential protective factor. And although others have not confirmed the association between a delayed disease onset and bilingualism in PPA individuals, 18 evidence from other neurodegenerative syndromes and aetiologies, 20, 21 warrants the need for future studies to include a monolingual PPA group. The high proportion of teachers in our sample (ca. 20% of the whole sample) is in consonance with a previous study 22 that identified an association between progressive speech and language disorders and the occupation of teaching. The significance of this finding regarding cognitive reserve and risk association remains unclear.
Only one patient had a reported history of a probable learning disability (dyslexia), which has been recognized as a risk factor for PPA. 23 Although medical history was unremarkable for most patients, the role of other possible risk factors, such as traumatic brain injury (for example, one of our PPA-L patients, with a previous history of traumatic brain injury, had an AD-consistent CSF biomarker profile) or cerebrovascular disease, has been less studied in PPA.
Besides the expected speech and language deficits, none of the patients showed significant abnormalities in the neurological examination: specifically, there were no findings suggestive of an associated syndrome within the FTLD spectrum, such as motor-neuron disease or atypical parkinsonism syndrome, all of which may present at onset with a primary progressive aphasia variant. However, this may be overlooked in a descriptive cross-sectional study, highlighting the need for longitudinal assessments, especially when considering the variability in PPA clinical trajectory. 1 Only 5 cases had information on AD-specific biomarkers, which would certainly be informative, particularly for PPA-L cases, given its frequent association with AD pathology, 24 as also shown in our data.
We focused our analysis on language impairment profiles based on naming, comprehension, semantic knowledge and repetition tasks. Information on other language domains, such as grammar, although important for correct diagnostic classification, 2,25 were scarce, therefore representing an important limitation. Word-finding was the most frequent first symptom, regardless of variant diagnosis, which is not surprising given that it is a quite frequent complaint in clinical contexts, heterogeneous in nature and associated with several neurodegenerative etiologies, presumably through different cognitive mechanisms and brain network vulnerabilities. 26 The general pattern of language impairment does seem to agree with the shared bilingual neural substrate hypothesis, as at least at the whole-group level, there was a tendency for parallel deterioration in both languages, in agreement with recent works on AD. 9, 27, 28 However, the results must be interpreted with caution given the methodological limitations of the study, particularly its limited sample size and lack of control over important linguistic mediating factors. These mediators, such as proficiency levels or the role of language distance, may partially explain differences in patterns of involvement in L1 and L2. For example, the eventual case of a more severe deficit in comprehension in L2 in the PPA-S group could be explained by a decrease in lexical-semantic access and retrieval, mediated by a combination of mediators presumably associated with L2 (eg, lower proficiency, later age of acquisition, rarer usage, and low cumulative exposition). 14 Future studies should consider the dynamic aspect of most linguistic mediators, such as proficiency, and include other sources of information, such as measures of cumulative proficiency and dominance. There is some evidence from stroke aphasia that L2 age of acquisition may interact with proficiency and dominance, but overall, it has been suggested that proficiency level and current language use may be more reliable determinants in bilingual aphasia, than age of acquisition, at least in specific language processes, such as lexical access. 14 Such dynamic aspects between language mediators are yet to be thoroughly researched in models of language impairment caused by neurodegenerative disorders, such as PPA.
Being a retrospective clinical-based study, most of the data was categorized to facilitate data comparability. This leads to a clear loss of range and statistical limitations, but also possible generalization restrictions, depending on how variables were operationalized. Similarly, through this reductionist approach, possible mediators may lose informative value when only assessed cross-sectionally. This limitation also relates to the difficulty in comparing data from different sources (previously published cases and new cases). Therefore, caution in the interpretation of results is warranted, as perspectives may differ in conceptual and methodological approaches.
Although diverse, particularly for L1, the array of languages included in this study is surely biased, as it does not even represent the most frequently spoken languages in the world or even the most frequent language families. As others have argued, 29 such a complex issue calls for the need of a worldwide global view, bearing in mind the complex interaction between multilingualism, cultural and educational factors, migration and dementia.
Nonetheless, the lack of attention given to multilingual PPA is probably associated with several issues, namely the lack of multilingual resources-both clinicians, and assessment tools. There are surely biases associated with how the language assessments themselves were conducted which hinder result interpretation. Formal language assessment in both languages was done for less than half of the patients in our sample. This may itself be a source of bias as available instruments are rarely validated in a multilingual context or this clinical population. We assume that for the remaining cases, the published data were derived mostly from qualitative assessments, based on third-party and patient reports, and from clinical examinations and impressions, which represents a source of considerable bias. The language and cultural background of the examiner may lead to over or underestimation of language deficits in L1 and L2. Beside measures of proficiency, 30 there are also a few tools developed for the evaluation of language in multilingual contexts, such as the Bilingual Aphasia Test, but these may not be sensitive enough to detect subtle deficits, as in mild PPA. The recent development of new tools specifically designed to assess language impairment in neurodegenerative disorders and primary progressive aphasia [31] [32] [33] will potentially become useful resources for multilingual PPA, once they are validated into different cultural and linguistic contexts.
The current lack of multilingual resources may also result in diagnostic delays. The shortest symptom onset time in our sample was 2 years, so we can assume that, at least, for a subsample of patients with longer disease duration, impairment in other cognitive domains was likely. Nevertheless, most studies reviewed here did not describe patient's performance on other cognitive domains, and information on nonverbal functions may improve discrimination between clinical syndromes. 34 The lack of information on other cognitive domains, may have been due to the severity of language impairment, which limits assessment of other cognitive domains with traditional language-based neuropsychological tools. The absence of information on other cognitive domains or behavioral symptoms also makes it difficult to explore the role of executive functions, 6 and specifically, executive control, as has been evaluated in bilingual aphasia due to stroke.
Despite several methodological limitations regarding data availability and biases, this work shows that the pattern of impairment in multilingual PPA patients is heterogeneous, with possible discrepancies between first and second languages, thus warranting the need for specific language assessment in both languages. Fundamentally, this study identifies current obstacles for a better understanding of multilingualism in PPA and substantiates the need for a global, prospective and longitudinal study.
